TG Therapeutics Completes Licensing Agreement With LFB Biotechnologies for the Development of Ublituximab Closes $25M Financing and Exchange Transaction With Manhattan Pharmaceuticals NEW YORK, March 2, 2012 (GLOBE NEWSW - New York Agreement - Document - PDFSEARCH.IO

First Page	Meta Content
	TG Therapeutics Completes Licensing Agreement With LFB Biotechnologies for the Development of Ublituximab Closes $25M Financing and Exchange Transaction With Manhattan Pharmaceuticals NEW YORK, March 2, 2012 (GLOBE NEWSW Add to Reading List Document Date: 2012-12-11 10:28:45 Open Document File Size: 38,96 KB Share Result on Facebook

TG Therapeutics Completes Licensing Agreement With LFB Biotechnologies for the Development of Ublituximab Closes $25M Financing and Exchange Transaction With Manhattan Pharmaceuticals NEW YORK, March 2, 2012 (GLOBE NEWSWAdd to Reading List